AI assistant
Sending…
Adaptive Biotechnologies Corp — Director's Dealing 2024
Mar 7, 2024
31660_dirs_2024-03-06_75786ca2-6f77-43dd-a180-efd8cb8d74a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2024-03-04
Reporting Person: HERSHBERG ROBERT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-04 | Common Stock | A | 31328 | — | Acquired | 107296 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | Stock Option (right to buy) | $3.99 | A | 48044 | Acquired | 2034-03-04 | Common Stock (48044) | Direct |
Footnotes
F1: The option will vest in equal monthly installments over one year from March 4, 2024, subject to continued service as a director through such vesting dates.
More from Adaptive Biotechnologies Corp
Annual Report
2026
Apr 24
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 4
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 6
Regulatory Filings
2026
Feb 5
Director's Dealing
2026
Feb 4